# A Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation

> **NCT00148148** · PHASE2 · COMPLETED · sponsor: **University Hospital Muenster** · enrollment: 75 (estimated)

## Conditions studied

- Hematopoietic Stem Cell Transplantation
- Fungus Diseases

## Interventions

- **DRUG:** caspofungin
- **DRUG:** liposomal amphotericin B

## Key facts

- **NCT ID:** NCT00148148
- **Lead sponsor:** University Hospital Muenster
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** —
- **Final completion:** 2007-12
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2008-01-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00148148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00148148, "A Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00148148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*